Aurora B: A New Prognostic Marker and Therapeutic Target in Cancer
Keywords: Aurora B; Aurora Inhibitors; Aurora kinase; Benzimidazoles; C. elegans; Cromosomal Passenger Complex; Cytokinesis Kinase; Drosophila; HESPERADIN; Histone Kinase; INner CENtromere Pro-tein (INCENP); Mi-totic Centromere-Associated Kinesin; Prognostic Marker; S. pombe; Saccharomyces cerevisiae; Spindle Checkpoint Kinase; Survivin; Testis Zinc Finger Protein (Tzfp); Tetrahymena thermophila; Therapeutic Target; Xenopus; acute lymphocytic leukemia; anaphase-promoting complex; aneuploidy; cancer; carcinoma; centrosome; chromosome; chronic mye-loid leukemia (CML); colon; cytokinesis; glioblastoma; hepatocellular carcinoma; indolinone; inhibitors; kinetochores; malignant en-dometrium; mesothelioma; microtubule-depolymerizing kinesin MCAK; mitosis; neoplastic lesions; oral cancer; phosphorylation; prometaphase; prostate; serine-threonine kinase; testicular germ; thyroid
Document Type: Research Article
Publication date: 01 February 2011
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content